Stay updated on GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page.

Latest updates to the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe page shows a routine version update from v3.4.2 to v3.4.3. No study content or data appears to have changed.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedGastric cancer has been added to the conditions section of the study page, including gastric/GEJ adenocarcinoma.SummaryDifference0.0%

- Check34 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding status notice and Revision: v3.4.1.SummaryDifference0.3%

- Check41 days agoChange DetectedA new site-wide notice about government funding lapse and NIH Clinical Center status was added, and the site revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check48 days agoChange DetectedMinor UI/text changes include adding a 'Show glossary' feature, adjusting QC-related labels (e.g., 'Last Update Submitted that Met QC Criteria' vs 'Last Update Submitted that meet QC Criteria'), updating FEAR Act data wording to 'No FEAR Act Data', and changing the revision tag from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 in the page footer, indicating a minor template update with no changes to study content or eligibility criteria; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB1275 Monotherapy and with Anti-PD1 in Solid Tumors Clinical Trial page.